Johan Sundell

Person

Molndal, SE

People

Patents Applicationslast 30 patents

Information Patent Application
CERTAIN OCTAHYDROFURO[3,4- B]PYRAZINES AS GLP-1 RECEPTOR MODULATORS
- Publication number 20250236627
- Publication date Jul 24, 2025
- AstraZeneca AB
- Magnus POLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CERTAIN 2,5-DIAZABICYCLO[4.2.0]OCTANES AND OCTAHYDROFURO[3,4-B]PYRA...
- Publication number 20250115612
- Publication date Apr 10, 2025
- AstraZeneca AB
- Magnus POLLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CERTAIN 3-AZABICYCLO[3.1.0]HEXANES AS GLP-1 RECEPTOR MODULATORS
- Publication number 20250066338
- Publication date Feb 27, 2025
- AstraZeneca AB
- Magnus POLLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CERTAIN 3-AZABICYCLO[3.1.0]HEXANES AS GLP-1 RECEPTOR MODULATORS
- Publication number 20250042882
- Publication date Feb 6, 2025
- AstraZeneca AB
- Magnus POLLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CERTAIN 2,5-DIAZABICYCLO[4.2.0]OCTANES AS GLP-1 RECEPTOR MODULATORS
- Publication number 20240417393
- Publication date Dec 19, 2024
- AstraZeneca AB
- Magnus POLLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isoindoline Derivatives For The Treatment Of Arrhythmias
- Publication number 20100298392
- Publication date Nov 25, 2010
- AstraZeneca AB
- Annika Bjore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEW COMPOUNDS I/418
- Publication number 20080015237
- Publication date Jan 17, 2008
- ASTRAZENECA AB
- Annika Bjore
- C07 - ORGANIC CHEMISTRY

Johan Sundell

Person

Patents Applicationslast 30 patents

CERTAIN OCTAHYDROFURO[3,4- B]PYRAZINES AS GLP-1 RECEPTOR MODULATORS

CERTAIN 2,5-DIAZABICYCLO[4.2.0]OCTANES AND OCTAHYDROFURO[3,4-B]PYRA...

CERTAIN 3-AZABICYCLO[3.1.0]HEXANES AS GLP-1 RECEPTOR MODULATORS

CERTAIN 3-AZABICYCLO[3.1.0]HEXANES AS GLP-1 RECEPTOR MODULATORS

CERTAIN 2,5-DIAZABICYCLO[4.2.0]OCTANES AS GLP-1 RECEPTOR MODULATORS

Isoindoline Derivatives For The Treatment Of Arrhythmias

NEW COMPOUNDS I/418